“…Along with previous findings (Scherbaum et al, 2005), financial aspects seemed to be important, at least among participants currently not in OST. Among OST patients, insufficient dosage and problems to comply with treatment regulations were the main reasons for NPU, which may point to a mismatch between patient expectations and the mode of OST delivery (Schulte, Gansefort, Stöver, & Reimer, 2009).…”